Introduction
Theoretical Models and Intervention Targets
Interventions’ Taxonomy
Promise and Current Limitations of Individual Risk Prediction
Theory-Driven Interventions
Overview of Preventive Interventions
Psychological or Behavioral Interventions
The Demise of Psychological Debriefing
Cognitive Behavioral Therapy (CBT)
Study | Design: groups (n) | Population | Intervention starting time* | Treatment sessions/ duration | Assessment time points* | Outcome measures | Results |
---|---|---|---|---|---|---|---|
Bryant et al. 1998 [50] | Exposure based CBT (12) SC (12) | MVA, industrial accidents survivors with ASD | <2 weeks | 5 weekly 1.5-h sessions | <2 weeks, 2 and 6 months | CIDI, IES, BDI, STAI | Fewer PTSD cases, and intrusive, avoidance, and depressive symptoms in CBT group at follow-ups |
Bryant et al. 1999 [51] | PE (14), PE + anxiety management (15) SC (16) | MVA, non- sexual assault survivors with ASD | <2 weeks | 5 weekly 1.5-h sessions | <2 weeks, 2 and 6 months | CAPS-2; IES, BDI, STAI | Fewer PTSD cases in PE and PE + anxiety management groups at follow-ups |
Ehlers et al. 2003 [52] | CT (28), self help (28), repeated assessment (29) | MVA Meeting PTSD diagnosis, PDS ≥ 20 | Around 3 months, < 6 months | Up to 12 weekly sessions. 1st session 90 min, afterwards 60 min | 2, 3, 6, and 12 months | CAPS, PDS, BAI, BDI, disability report | Fewer PTSD cases, less PTSD, depression, anxiety symptoms, and reduced disability in CT group at follow-ups |
Bisson et al. 2004 [38] | Exposure based CBT (76) Standard care (76) | Physical injury, meet PTSD criteria on PDS, HADS >15, or IES >35 | 5–10 weeks | 4 weekly 1-h sessions | 1–3 weeks, 12 weeks, and 13 months | CAPS, IES | Fewer PTSD symptoms, similar PTSD cases in CBT group at follow-ups |
Bryant et al. 2006 [53] | Exposure based CBT (33) CBT + hypnosis (30) SC (24) | MVA, non-sexual assault survivors with ASD | <2 weeks | 6 weekly sessions | Pre-treatment, Post-treatment, 6 months and 3 years | CAPS, IES, BDI, STAI | Fewer PTSD cases in CBT and CBT + hypnosis groups at follow-ups |
Foa et al. 2006 [54] | Brief CBT (31) Assessment alone (30) SC (29) | Female victims of assaults, meet symptom criteria for PTSD | 1 month | 4 weekly 2-h sessions | Pre-treatment, post-treatment, 3 and 9 months | SCID, PSS, BDI, BAI, SAI | Greater decreases in PTSD severity in CBT group after treatment and at 3 months. No group difference at 9 months. |
Sijbrandij et al. 2007 [40] | Brief CBT (79) Waitlist Control (64) | Assault, accidents, witness, etc. Meeting acute PTSD | <3 months | 4 weekly 120-min sessions | Pre-treatment, 1 week and 4 months after treatment | SCID | Accelerated recovery in the CBT group after treatment; no difference in long term outcome |
Bryant et al. 2008 [37] | Exposure based CBT (30),Cognitive restructuring (30) Waitlist (30). | MVA, non-sexual assault, preliminary diagnosis of ASD | <1 month | 5 weekly 90-min sessions with daily homework | Pre-treatment, post-treatment, 6 months | CAPS, BDI, BAI, PTCI | Fewer PTSD in CBT group, not in cognitive restructuring group at follow-ups |
Freyth et al. 2010 [39] | PE (19), SC (21) | Accident, assault victims, with ASD diagnosis | 21 days | 3 weekly sessions (90, 60, 60 min) | Pre-treatment, 1 week after treatment, 3 months, 4 years (telephone) | IES-R, DQ, PTCI, STAI, BDI | No significant group difference in symptomatic improvement. |
Irvine et al. 2011 [43] | CBT (96) Usual care (97) | Cardioverter defibrillator patients | <2 months | 8 weekly telephone-based counseling sessions | Before hospital discharge, 6 and 12 months | HADS, IES-R, Crown-Crisp Experiential Summary, SF-36 | Significant PTSD symptom improvements in CBT group at follow-ups |
Shalev et al. 2012 [41•] | PE (63), CT (40), Escitalopram (23), placebo (23) Waiting List/ Delayed PE (93) | ER trauma survivors, PTSD diagnosis (without duration criteria) | 20 days | 12 weeks | 9 days, 20 days, 5 months, 9 months | CAPS, SCID, PSS-SR | Lower 5-month prevalence of PTSD in PE and CT. No 9-month difference between early and delayed PE |
Rothbaum et al. 2012 [36•] | Modified PE (69) Assessment only (n = 68) | Rape, assault, MVA, meet Criterion A | 12 hours | 3 weekly 60-min sessions | 12 h, 4 and 12 weeks | PSS-I, BDI, PDS | Lower PTSD symptoms at follow-ups, especially in sexual assault victims |
Brunet et al. 2013 [55] | Dyadic CBT (37), control (37) | MVA, other accidents, physical assault, meet Criterion A1 and A2 | About 25 days | 2 sessions, 2 weeks apart | Pre-treatment (21 days), mid-treatment (35 days), post-treatment (3 months) | IES-R, CAPS, SCS, SAS-SR | Less PTSD symptoms in dyadic CBT group post-treatment |
Shaw et al. 2014 [56] | TF-CBT 6 session (33), TF-CBT (29), comparison (1-session education) (43) | Mothers of pre-mature infants, above clinical threshold in any one of BAI, BDI, and SASRQ | 2 weeks | 6 or 9 sessions, 1–2 sessions/week, 45–55 min/session | 1–2 weeks after childbirth, 4/5 weeks, 6/7 weeks (for 9-session TF-CBT group) and 6 months | DTS, SASRQ, BDI-II, BAI, MINI | Significantly fewer PTSD, anxiety and depression symptoms in CBT group at follow-ups. No difference in effect size between 6-and 9-session interventions. |
Pharmacological Interventions
Study | Design: groups (n) | Population | Intervention starting time* | Treatment duration | Assessment time points* | Outcome measures | Results |
---|---|---|---|---|---|---|---|
Schelling et al. 2001 [66] | Hydrocortisone 18 mg/kg/h iv (9), control (11) | Septic shock | During shock phase in hospital | 6 days + 12 days taper | 2+ years (31 months) | SCID traumatic memory PTSS-10 | 11 % PTSD in placebo group, 64 % PTSD in treatment group |
Pitman et al. 2002 [60] | Propranolol 40 mg 4x/day (11); placebo (20) | ER trauma survivors, meet A1 + A2 criteria | <6 h | 10 days + 9 days taper | 1 month, 3 months | CAPS, psychophysiological imagery procedure | Lower mean of CAPS score, and less physiologic responders in propranolol group during follow-ups |
Schelling et al. 2004 [67] | Hydrocortisone 10 mg/h iv (26); control (22) | High risk inflammation patients after cardiopulmonary bypass | Before surgery | 24 h + 3 days taper | 6 months | Traumatic memory PTSS-10 | Slightly lower symptoms in treatment group at 6 months, weak evidence |
Stein et al. 2007 [61] | Propranolol 40 mg 3x/day(17); gabapentin 400 mg 3x/day(14); placebo (17) | Physical injury in trauma center | <48 h | 2 days uptitration, 8 days acute treatment, 4 days taper | In hospital, 1, 4, and 8 months | PCL-C, CES-D, ASDS, CIDI | Neither study drug showed a significant benefit over placebo on depressive or posttraumatic stress symptoms |
Hoge et al 2012 [62•] | Propranolol 240 mg/day (22), placebo (21) | ER trauma survivors, meet A1 + A2 criteria | <12 h | 10 days + 9 days taper | 4 weeks, 12 weeks | CAPS, SCID | CAPS score and PTSD diagnosis no difference |
Shalev et al. 2012 [41•] | PE (63), CT (40), Escitalopram 20 mg/day (23), placebo (23), waiting list/ delayed PE (93) | ER trauma survivors, PTSD diagnosis (without duration criteria) | 20 days | 12 weeks | 9 days, 20 days, 5 months, 9 months | CAPS, SCID, PSS-SR | No difference between escitalopram and placebo groups |
Delahanty et al. 2013 [48•] | Hydrocortisone 20 mg 2x/day. oral (31); placebo (33) | Traumatic injury, PDEQ > 27 | <12 h | 10 days + 6 days taper | ER, 1 month, 3 months | CAPS, CES-D, SF-36 | Lower CAPS, more improvement in depression and quality of life in treatment group at follow-ups |
Suliman et al. 2015 [68] | Escitalopram 20 mg/day (12); placebo (17) | Assault, MVA, witnessing, met intrusion or hyperarousal criteria of ASD | <4 weeks | 24 weeks | <4 weeks, 1, 3, 6, 8, 10 months | CAPS, CGI, MINI, MADRS, VAS-D/A, SDS | No difference between groups |